• Trajectory description analysis may provide a more nuanced picture of depressive status of patients.
OBJECTIVE
• The objective of this study was to identify, in a large sample of patients with schizophrenia, distinct groups of patients with different trajectories of depressive symptoms.
METHODS
• We used data from EuroSC, a European 2-year cohort study conducted in France, England and Germany, included 1208 patients, who answered the Calgary Depression Scale for Schizophrenia (CDSS) questionnaire every 6 months for up to 2.
[1]
• The Calgary Depression Scale for Schizophrenia (CDSS), developed to assess the level of depressive symptoms in schizophrenia, was completed every 6 months, as well as other clinical outcomes (severity of symptoms, functioning, etc.) and quality of life.
• The CDSS is a 9-items questionnaire (depression, hopelessness, self-depreciation, guilty ideas of reference, pathological guilt, morning depression, early wakening, suicide, observed depression) with a global score range of 0-27.
• To identify patients suffering from depressive symptoms, widely accepted cut-off score of the CDSS were applied:  cut-off score of >3 points and >6 points have been proposed to separate depressed and non-depressed patients. [2] [3] [4] [5] [6] [7] [8] • Depression rates were calculated at each visit, independently, and depending on the patient's previous status.
RESULTS
• Our sample consisted of 1208 patients with schizophrenia at the baseline visit.
• The mean CDSS score at baseline was 2.88 (SD 3.57). (Table 1) • The prevalence of depressive symptoms were 20% to 40% depending on CDSS cut-off used.
• Among the 477 and 243 patients considered as depressive at baseline, 42% and 60% changed status after 6 months when considering cut-points of 3 and of 6, respectively. (Figure 1) • Similarly, among the 724 and 958 patients considered as nondepressive at baseline, 18% and 10% changed status after 6 months. (Figure 1) • These results were relatively stable over time, when considering the subsequent visits. (Figure 1 • This study highlights the need of cut-off to be used in CDSS, to define patients with depressive symptoms. 
